Furthermore, we showed that liver biopsies with NASH had a significant upregulation of fibrogenic genes coding for TGF-β, ACTA2, and TIMP1 (Figure 9G), consistent with NASH scores in patients with NASH (Supplemental Table 2). Here, ACTA2 is linked to metabolic dysfunction-associated steatohepatitis.